Company: PRME
Filing Date: 2025-07-31
Form Type: 8-K
Source: 0001628280-25-037076
Chunk: 3

Company: Prime Medicine, Inc.
Filing Date: 2025-07-31
Form: 8-K
Item: Item 9.01
Chunk 3
---
Item 9.01 - Financial Statements and Exhibits

(d) Exhibits

  Exhibit      Description                                                                                                                                                                                           
   Number                                                                                                                                                                                                            
      1.1      Underwriting Agreement, dated July 30, 2025, by and between Prime Medicine, Inc., TD Securities (USA) LLC and BMO Capital Markets Corp., as representatives of the several underwriters listed on...  
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
      5.1      Opinion of Goodwin Procter LLP.                                                                                                                                                                       
     23.1      Consent of Goodwin Procter LLP (included in Exhibit 5.1).                                                                                                                                             
      104      Cover Page Interactive Data File (embedded within the Inline XBRL document)                                                                                                                           

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: July 31, 2025

  Prime Medicine, Inc.                               
  By:                       /s/ Allan Reine          
  Name:                     Allan Reine, M. D.       
  Title:                    Chief Executive Officer